Bringing Substance Use Treatment into the 21st Century

By Lindsey Browning, Senior Policy Analyst Last week the United States Senate Committee on Health, Education, Labor & Pensions held a hearing to examine options to address the poor outcomes our health system delivers for those with mental illnesses. I was struck by the general agreement among senators and witnesses...

Continue reading

NAMD Supports Payment Adjustment for Duals-Focused Plans; CMS Finalizes 90/10 E&E Funding; Senate Advances Reconciliation Bill Repealing ACA Provisions; MACPAC Releases 2015 Medicaid Data Book

NAMD Update Update December 8, 2015 From the NAMD Desk   RECAP: Hot Topics at NAMD’s December All-Director Call Last week, NAMD held its monthly all-Director calls for states to discuss policy and operational issues. During the call, participants discussed a range of issues, including: CMS engagement with states on...

Continue reading

HHS Forum on Pharmaceuticals

HHS recently convened a multi-stakeholder meeting on pharmaceutical access, affordability and innovation. While the impetus behind the meeting was at least in part due to ongoing conversations with states around Medicaid’s attempts to balance access and affordability, the meeting enabled many other stakeholders (consumers and patients, insurers, manufacturers, and others)...

Continue reading

APMs: Getting it Right across Payers

Much of the attention around the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) has focused on the overhaul of Medicare’s fee-for-service payment system. Equally, if not more, transformative is the provision of MACRA that seeks to incent alternative payment methodologies (APMs) across payers starting in 2021. As leaders...

Continue reading